Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 342

1.

Heterotopic ossification.

Kaplan FS, Glaser DL, Hebela N, Shore EM.

J Am Acad Orthop Surg. 2004 Mar-Apr;12(2):116-25. Review.

PMID:
15089085
2.

Exoneration of NF-kappaB dysregulation in fibrodysplasia ossificans progressiva.

Ahn J, Feldman G, Terry L, Shore EM, Kaplan FS.

Clin Orthop Relat Res. 2003 Jan;(406):205-13.

PMID:
12579020
3.
4.

Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis.

Ahn J, Serrano de la Pena L, Shore EM, Kaplan FS.

J Bone Joint Surg Am. 2003 Apr;85-A(4):667-74.

PMID:
12672843
5.

Osteogenic induction in hereditary disorders of heterotopic ossification.

Shore EM, Glaser DL, Gannon FH.

Clin Orthop Relat Res. 2000 May;(374):303-16. Review.

PMID:
10818990
6.

Hematopoietic stem-cell contribution to ectopic skeletogenesis.

Kaplan FS, Glaser DL, Shore EM, Pignolo RJ, Xu M, Zhang Y, Senitzer D, Forman SJ, Emerson SG.

J Bone Joint Surg Am. 2007 Feb;89(2):347-57.

PMID:
17272450
7.

Limb swelling in patients who have fibrodysplasia ossificans progressiva.

Moriatis JM, Gannon FH, Shore EM, Bilker W, Zasloff MA, Kaplan FS.

Clin Orthop Relat Res. 1997 Mar;(336):247-53.

PMID:
9060511
8.

Lumbar puncture and surgical intervention in a child with undiagnosed fibrodysplasia ossificans progressiva.

Zaghloul KA, Heuer GG, Guttenberg MD, Shore EM, Kaplan FS, Storm PB.

J Neurosurg Pediatr. 2008 Jan;1(1):91-4. doi: 10.3171/PED-08/01/091.

PMID:
18352811
9.

Fibrodysplasia ossificans progressiva.

Blaszczyk M, Majewski S, Brzezinska-Wcislo L, Jablonska S.

Eur J Dermatol. 2003 May-Jun;13(3):234-7.

PMID:
12804980
10.

Role of altered signal transduction in heterotopic ossification and fibrodysplasia ossificans progressiva.

Shore EM, Kaplan FS.

Curr Osteoporos Rep. 2011 Jun;9(2):83-8. doi: 10.1007/s11914-011-0046-3. Review.

11.

Dysregulation of the BMP-4 signaling pathway in fibrodysplasia ossificans progressiva.

Kaplan FS, Fiori J, DE LA Peña LS, Ahn J, Billings PC, Shore EM.

Ann N Y Acad Sci. 2006 Apr;1068:54-65. Review.

PMID:
16831905
12.

Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva.

Shafritz AB, Shore EM, Gannon FH, Zasloff MA, Taub R, Muenke M, Kaplan FS.

N Engl J Med. 1996 Aug 22;335(8):555-61.

13.

Heterotopic Ossification: Two Rare Forms and What They Can Teach Us.

Kaplan FS, Hahn GV, Zasloff MA.

J Am Acad Orthop Surg. 1994 Oct;2(5):288-296.

PMID:
10709021
14.

Fibrodysplasia ossificans progressiva: searching for the skeleton key.

Kaplan FS, Shore EM, Zasloff MA.

Calcif Tissue Int. 1996 Aug;59(2):75-8. No abstract available.

PMID:
8687972
15.

Pseudomalignant heterotopic ossification.

Kaplan FS, Gannon FH, Hahn GV, Wollner N, Prauner R.

Clin Orthop Relat Res. 1998 Jan;(346):134-40.

PMID:
9577421
16.

Fibrodysplasia ossificans progressiva: clinical and genetic aspects.

Pignolo RJ, Shore EM, Kaplan FS.

Orphanet J Rare Dis. 2011 Dec 1;6:80. doi: 10.1186/1750-1172-6-80. Review.

17.

A new era for fibrodysplasia ossificans progressiva: a druggable target for the second skeleton.

Kaplan FS, Glaser DL, Pignolo RJ, Shore EM.

Expert Opin Biol Ther. 2007 May;7(5):705-12. Review.

PMID:
17477807
18.

Characterization of bone morphogenetic protein 4 receptor in fibrodysplasia ossificans progressiva.

Lanchoney TF, Olmsted EA, Shore EM, Gannon FA, Rosen V, Zasloff MA, Kaplan FS.

Clin Orthop Relat Res. 1998 Jan;(346):38-45.

PMID:
9577408
19.

Inherited human diseases of heterotopic bone formation.

Shore EM, Kaplan FS.

Nat Rev Rheumatol. 2010 Sep;6(9):518-27. doi: 10.1038/nrrheum.2010.122. Epub 2010 Aug 10. Review.

20.

[Fibrodysplasia ossificans progressiva and osteoimmunology].

Katagiri T.

Clin Calcium. 2016 May;26(5):691-8. doi: CliCa1605691698. Review. Japanese.

PMID:
27117614

Supplemental Content

Support Center